P&K Skin Research Center Co., Ltd.

KOSDAQ:A347740 Stock Report

Market Cap: ₩62.0b

P&K Skin Research Center Valuation

Is A347740 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A347740 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A347740 (₩2145) is trading below our estimate of fair value (₩5694.76)

Significantly Below Fair Value: A347740 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for A347740?

Key metric: As A347740 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for A347740. This is calculated by dividing A347740's market cap by their current earnings.
What is A347740's PE Ratio?
PE Ratio11.6x
Earnings₩5.36b
Market Cap₩61.95b

Price to Earnings Ratio vs Peers

How does A347740's PE Ratio compare to its peers?

The above table shows the PE ratio for A347740 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.6x
A359090 C&R Research
12.5xn/a₩64.4b
A223250 DreamCIS
19.8xn/a₩75.4b
A238120 Aligned Genetics
14.3xn/a₩47.3b
A215380 WOOJUNG BIO
23.8xn/a₩28.2b
A347740 P&K Skin Research Center
11.6xn/a₩62.0b

Price-To-Earnings vs Peers: A347740 is good value based on its Price-To-Earnings Ratio (11.6x) compared to the peer average (17.6x).


Price to Earnings Ratio vs Industry

How does A347740's PE Ratio compare vs other companies in the Asian Life Sciences Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
A347740 11.6xIndustry Avg. 31.9xNo. of Companies8PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: A347740 is good value based on its Price-To-Earnings Ratio (11.6x) compared to the Asian Life Sciences industry average (30.8x).


Price to Earnings Ratio vs Fair Ratio

What is A347740's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A347740 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio11.6x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate A347740's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies